Fortive Corp

Listed Company

FTVCIK 0001659166NYSELarge AcceleratedIndustrial Instruments For Measurement, Display, And ControlDelawareFY ends Dec 31

Period

FY 2025

Revenue

$4.16B

Net Income

$579.20M

Total Assets

$11.74B

Equity

$6.45B

Shares Out

304.86M

Op. Cash Flow

$1.08B

Business

Fortive Corp provides essential technologies and connected workflow solutions for a range of industrial and healthcare end markets. The company designs, develops, manufactures, and services professional and engineered products, software, and services such as instrumentation, sensing and measurement tools, sterilization and biomedical solutions, and clinical productivity software. It operates through three reportable segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. Fortive sells globally across North America, Europe, and Asia through subsidiaries, direct sales, distributors, and channel partners.

Summary from filing dated 2025-02-25

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Total sales	4,159	4,081	3,914	5,826	5,255
Total cost of sales	−1,518	−1,462	−1,437	−2,462	−2,248
Gross profit	2,641	2,619	2,477	3,363	3,007
Selling, general, and administrative	−1,662	−1,652	−1,666	−1,957	−1,840
Research and development	−259	−251	−237	−402	−355
Operating profit	720	716	574	987	813
Interest expense, net	−121	−153	−124	−98	—
Other non-operating income (expenses), net	3	−57	−17	−16	−14
Earnings from continuing operations before income taxes	602	506	433	874	678
Income taxes	−70	−24	−25	−118	−63
Net earnings from continuing operations	533	483	408	—	—
Net earnings from discontinued operations	47	350	457	—	—
Net earnings	579	833	866	755	—
Basic (in dollars per share)	1.6	1.38	1.16	2.12	1.66
Diluted (in dollars per share)	1.59	1.37	1.15	2.1	1.65
Basic (in dollars per share)	0.14	1.01	1.3	0	−0.02
Diluted (in dollars per share)	0.14	0.99	1.28	0	−0.02
Basic (in dollars per share)	1.74	2.39	2.46	2.12	1.64
Diluted (in dollars per share)	1.73	2.36	2.43	2.1	1.63
Basic (in shares)	332	349	353	356	349
Diluted (in shares)	335	353	356	361	352

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and equivalents	376	813	1,889	709	819
Accounts receivable less allowance for doubtful accounts of $18.8 and $19.4, respectively	684	661	961	959	930
Finished goods	170	152	214	—	—
Work in process	12	15	109	—	—
Raw materials	110	103	214	—	—
Inventories	292	270	537	537	513
Prepaid expenses and other current assets	234	234	285	273	253
Current assets, discontinued operations	21	614	—	—	0
Total current assets	1,606	2,592	3,672	2,477	2,515
Property, plant and equipment, net	270	233	440	422	396
Other assets	376	348	519	456	513
Goodwill	7,298	7,216	7,265	9,049	9,152
Other intangible assets, net	2,188	2,531	3,160	3,487	3,890
Other assets, discontinued operations	0	4,096	—	—	—
Total assets	11,738	17,016	16,912	15,891	16,466
Long-Term Debt, Current Maturities	900	376	0	1,000	2,152
Trade accounts payable	436	425	609	623	558
Accrued expenses and other current liabilities	911	868	1,183	1,104	1,005
Current liabilities, discontinued operations	0	569	—	—	0
Total current liabilities	2,247	2,238	1,791	2,727	3,715
Other long-term liabilities	724	847	1,149	1,223	1,426
Long-term debt	2,307	3,331	3,646	2,252	1,807
Long-term liabilities, discontinued operations	0	404	—	—	—
Commitments and Contingencies (Note 12)	—	—	—	—	—
Common stock: $0.01 par value, 2,000 shares authorized; 369.6 and 366.6 issued; 313.4 and 341.2 outstanding; respectively	4	4	4	4	4
Additional paid-in capital	4,210	4,035	3,851	3,706	3,670
Treasury shares, at cost	−3,230	−1,612	−716	—	—
Retained earnings	5,429	8,228	7,506	6,742	6,024
Accumulated other comprehensive income (loss)	41	−465	−326	−326	−185
Total Fortive stockholders equity	6,453	10,189	10,319	9,683	9,512
Noncontrolling interests	8	7	6	5	5
Total stockholders equity	6,461	10,196	10,325	9,689	9,517
Total liabilities and equity	11,738	17,016	16,912	15,891	16,466

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Amortization	368	369	367	382	321
Depreciation	70	62	59	84	75
Stock-based compensation	117	90	95	94	77
Loss from equity investments	0	39	17	17	—
Change in deferred income taxes	−50	−25	−84	−62	−41
Change in accounts receivable, net	9	−16	−700,000	−52	−84
Change in inventories	−20	−8	8	−40	−54
Change in trade accounts payable	12	51	2	81	73
Change in prepaid expenses and other assets	−16	10	−65	−7	−35
Change in accrued expenses and other liabilities	13	−27	27	42	28
Total operating cash provided by continuing operations	1,036	1,029	833	1,303	993
Total operating cash provided by discontinued operations	48	498	520	0	−32
Net cash provided by operating activities	1,083	1,527	1,354	1,303	961
Purchases of property, plant and equipment	−105	−86	−79	−96	−50
Cash paid for acquisitions, net of cash received	−26	−4	−96	−13	−2,570
All other investing activities	11	900,000	1	−4	0
Total investing cash used in continuing operations	−120	−89	−173	−103	−2,616
Total investing cash used in discontinued operations	−16	−1,707	−22	0	0
Net cash used in investing activities	−135	−1,796	−195	−103	−2,616
Net proceeds from (repayments of) commercial paper borrowings	900,000	−597	840	39	365
Repurchase of common shares	−1,610	−890	−273	−443	0
Payment of dividends	−92	−111	−102	−100	−98
Proceeds from borrowings (maturities greater than 90 days), net of issuance costs	0	1,734	549	1,394	1,000
Repayment of borrowings (maturities greater than 90 days)	−716	−1,000	−1,000	−1,000	−611
Proceeds from Ralliant Dividend	1,150	0	0	0	0
All other financing activities	41	71	18	−7	31
Total financing cash (used in) provided by continuing operations	−1,226	−793	32	−1,273	652
Total financing cash used in discontinued operations	−160	0	0	0	0
Net cash provided by (used in) financing activities	−1,387	−793	32	−1,273	652
Effect of exchange rate changes on cash and equivalents	1	−14	−11	−38	−3
Net change in cash and equivalents	−438	−1,076	1,180	−110	−1,006

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro